Clinical Trial Update: Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative Steroids [Phase 3]

View source ↗

Summary

A Phase 3 trial in pediatric de novo liver transplant recipients evaluated basiliximab in combination with cyclosporine (including cyclosporine microemulsion) a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Basiliximab (basiliximab)
• CYCLOSPORINE (cyclosporine)
• cyclosporine microemulsion (cyclosporine)
• steroids

Snippet

Sponsor: Novartis | Conditions: Liver Transplantation, Infection | Phase 3 | Status: COMPLETED | Results posted: 2011-09-22